92 related articles for article (PubMed ID: 3530449)
1. High-dose cisplatin in the treatment of advanced adenocarcinoma of the colon and rectum: a Southeastern Cancer Study Group trial.
DeSimone PA; Davila E; Jochimsen PR; Bartolucci AA
Cancer Treat Rep; 1986 Oct; 70(10):1229-30. PubMed ID: 3530449
[No Abstract] [Full Text] [Related]
2. Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.
O'Connell MJ; Moertel CG; Rubin J; Schutt AJ; Creagan ET
Cancer Treat Rep; 1980; 64(2-3):311-3. PubMed ID: 7190870
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine.
Fraile RJ; Samson MK; Buroker TR; O'Bryan R; Baker LH; Vaitkevicius VK
Cancer Treat Rep; 1978 Oct; 62(10):1599-601. PubMed ID: 361229
[TBL] [Abstract][Full Text] [Related]
4. [cis-Dichlorodiammine platinum (II) in the treatment of advanced colo-rectal cancer].
Dozono H; Moriya Y; Saijo N; Fujita J; Koyama Y
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1465-9. PubMed ID: 2990351
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
Fiore J; Kemeny N; Raymond V; Young C
Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
[No Abstract] [Full Text] [Related]
6. Treatment of metastatic colorectal carcinoma with cisplatin and 5-FU.
Shepard KV; Faintuch J; Bitran JD; Sweet DL; Robin E; Levin B
Cancer Treat Rep; 1985 Jan; 69(1):123-4. PubMed ID: 4038471
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of maytansine in patients with advanced colorectal carcinoma.
O'Connell MJ; Shani A; Rubin J; Moertel CG
Cancer Treat Rep; 1978 Aug; 62(8):1237-8. PubMed ID: 356981
[No Abstract] [Full Text] [Related]
8. Pilot trial of prolonged continuous-infusion 5-fluorouracil and weekly cisplatin in advanced colorectal cancer.
Cantrell JE; Hart RD; Taylor RF; Harvey JH
Cancer Treat Rep; 1987 Jun; 71(6):615-8. PubMed ID: 3555789
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
[No Abstract] [Full Text] [Related]
10. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
Togni P; Sessa C; Varini M; Cavalli F
Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
[TBL] [Abstract][Full Text] [Related]
11. Mitomycin and methotrexate: negative experience in untreated colorectal carcinoma.
Wernz JC; Kao AK; Muggia FM; Asbury RF
Cancer Treat Rep; 1985 Feb; 69(2):223-4. PubMed ID: 3918793
[No Abstract] [Full Text] [Related]
12. [Intraperitoneal cisplatin in peritoneal carcinomatosis patients].
Toi M; Shiramizu T; Yonemura T; Ezaki T; Oka N; Yoshida T; Tsurumaru H
Gan No Rinsho; 1985 May; 31(5):522-6. PubMed ID: 4040582
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ
Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866
[TBL] [Abstract][Full Text] [Related]
14. Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer.
O'Connell MJ; Rubin J; Hahn RG; Kvols LK; Moertel CG
Cancer Treat Rep; 1987 Mar; 71(3):333-4. PubMed ID: 3815402
[No Abstract] [Full Text] [Related]
15. [Treatment of advanced colonic and rectal adenocarcinoma: combination of 5-FU and high-dose folinic acid].
Rougier P; Droz JP; Ducreux M; Kac J; Spielmann M; Crespon B; Ley G; Zimmermann P; Theodore C; Chavy A
Bull Cancer; 1983; 70(5):434-6. PubMed ID: 6607759
[No Abstract] [Full Text] [Related]
16. Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial.
Locker GY; Lanzotti V; Sweet D; Lad T; Khandekar J; Stiff P; Johnson C; Miller S
Cancer Treat Rep; 1984 Oct; 68(10):1303-4. PubMed ID: 6525605
[No Abstract] [Full Text] [Related]
17. Phase II study of cyclophosphamide and cytarabine in the treatment of metastatic adenocarcinoma of the colon and rectum.
Denefrio JM; Kaplan RS; Eisenberger MA; Lessner HE
Cancer Treat Rep; 1981; 65(1-2):163-4. PubMed ID: 7226166
[No Abstract] [Full Text] [Related]
18. Protracted low-dose cisplatin infusion in advanced colorectal cancer.
Lokich J; Zipoli T; Greene R; Paul S; Sonnenborn H; Moore C
Cancer Treat Rep; 1986 Apr; 70(4):523-4. PubMed ID: 3698046
[TBL] [Abstract][Full Text] [Related]
19. [Antiblastic therapy of nonadvanced colorectal cancer: preliminary results of a randomized therapeutic trial].
Bertoldi I; Barzi A; Cavaleri V; D'Avena C; De Vecchis L; Mangialardi N; Chirletti P
Ann Ital Chir; 1982; 54(1):77-85. PubMed ID: 6756248
[No Abstract] [Full Text] [Related]
20. Phase II trial of mitoxantrone in advanced colorectal cancer.
Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
[No Abstract] [Full Text] [Related]
[Next] [New Search]
